Global strategic partnership joins execution management with an open, hybrid cloud approach to help drive flexibility and speed for enterprise digital transformation
Celonis, IBM and Red Hat announced a global strategic partnership to help accelerate the adoption of the Celonis Execution Management System (EMS) and help deliver more flexibility and choice in how customers deploy the technology. The collaboration seeks to accelerate how customers apply process mining, intelligence and automation to the core enterprise system functions and processes that drive business execution.
The strategic partnership aims to help address many challenges business leaders face as they seek to digitally transform their operations. Despite trillions of dollars invested in technologies, solutions, and transformation initiatives, businesses often execute below their full capacity because of system and technology complexity, broken or inefficient processes, and fragmented data that sits across various IT and cloud environments. Celonis EMS sits on top of core enterprise systems such as Enterprise Resource Planning and Customer Relationship Management, pulls real-time data from them, and applies process intelligence in order to help identify and unlock execution capacity across a business.
IBM Hybrid Cloud, High Performance Computing, Artificial Intelligence, and Quantum Computing technologies to serve as foundation for newly launched Cleveland Clinic Global Center for Pathogen Research & Human Health
Cleveland Clinic and IBM (NYSE: IBM) have announced a planned 10-year partnership to establish the Discovery Accelerator, a joint Cleveland Clinic - IBM center with the mission of fundamentally advancing the pace of discovery in healthcare and life sciences through the use of high performance computing on the hybrid cloud, artificial intelligence (AI) and quantum computing technologies.
The collaboration is anticipated to build a robust research and clinical infrastructure to empower big data medical research in ethical, privacy preserving ways, discoveries for patient care and novel approaches to public health threats such as the COVID-19 pandemic. Through the Discovery Accelerator, the researchers plan to use advanced computational technology to generate and analyze data to help enhance research in the new Global Center for Pathogen Research & Human Health, in areas such as: genomics, single cell transcriptomics, population health, clinical applications, and chemical and drug discovery.
See all Archived IBM News articles
See all articles from this issue